Market News & Analysis

Top Story

HSBC's Rebound Looks Far From Convincing

HSBC’s share price plummeted as the coronavirus outbreak spread, wreaking havoc on global economies and markets. 

Q1 results
Q1 results provided an insight as to the damage that covid-19 is causing. Profits at the bank tanked amid a surge in money set aside for bad loans. 

HSBC set aside $3 billion for bad loans, an increase of over 400% compared to the same period last year. This included a $600 million charge to cover the losses related to the collapse of Hin Leong Trading, one of Asia’s largest oil trading corporations.

Its also worth keeping in mind that this could just be the tip of the iceberg. HSBC warned that the $3 billion figure could rise further across the year, potentially to $7 - $10 billion. Clearly this would have a significant and material impact on profits; the $3 billion charge resulted in profits halving to $3.2 billion, revenue on the other hand dropped 5% to $13.7 billion.

One of the main differences between now and the Financial crisis, is the bank’s ability to absorb credit losses. Tier 1 capital ratio barely declined to 14.6% from 14.7%. However, this could fall further should provisions for bad loans rise.

Net Interest Income 
With central banks slashing interest rates to historically low levels, bank’s NII is coming under pressure. NII at HSBC fell to 1.54% in Q1, down from 1.56% previously and down from 1.59% the previous year. Central banks are unlikely to start raising interest rates anytime soon, in fact there is significantly more chance of further cuts than any hikes, meaning downward pressure will remain on this revenue stream.

Trading has been a brighter spot given the recent volatility in the markets amid the coronavirus crisis. However, the markets are now considerably calmer, meaning revenue is unlikely to get the same boost from trading going forward.

HSBC will continue its pivot towards Asia under newly appointed CEO Noel Quinn, a sensible plan given that it makes most of its money in Asia. These plans are on hold for the covid-19 crisis; however, the plan is expected to pick up from where it left off.

Analysts Rating
There are 22 analyst covering HSBC :
  • 4 Rate Buy
  • 6 Neutral
  • 12 Sell

Levels to watch:
HSBC continues to trade around -31% down from its pre-coronavirus crisis 590p level in mid-February, as it underperforms the broader market. The FTSE is down -21% from its mid-February pre-covid-19 level. The bank has seen an anaemic bounce from its covid-19 low, gaining just 5%, compared to the FTSE’s 17% rally.
HSBC trades below its 50 & 100 sma on the 4-hour chart; a bearish chart.
Immediate resistance can be seen at 408p (50 sma) and 430 (100 sma). A move above the 430p could negative the down trend and see more bulls jump in, opening the door to 436p and 450p
Immediate support is 395p (low 4th May) prior to 387p (low 2nd April).


This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

GAIN Capital Singapore Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the GAIN Capital group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), GAIN Capital Singapore Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact GAIN Capital Singapore Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither GAIN Capital Singapore Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

GAIN Capital Singapore Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit for the complete Risk Disclosure Statement.

Important Notice:

Cryptocurrencies are not legal tender currency and trading of derivatives on Cryptocurrencies are currently not covered under any regulatory regime in Singapore. Consequently, investors should be aware they do not have protection under the Securities and Futures Act (Cap. 289). Please ensure that you are fully aware of the risks.